Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mid-Atlantic Permanente Medical Group (MAPMG) is a premier multi-specialty medical group that provides exclusive healthcare services to Kaiser Permanente members in the District of Columbia, Maryland, and Virginia. Comprising over 1,700 physicians across more than 60 specialties, MAPMG operates within an integrated care delivery system that emphasizes preventive medicine, evidence-based clinical practices, and advanced health informatics. The organization is consistently recognized for clinical excellence, frequently ranking at the top of NCQA quality ratings for patient outcomes and satisfaction. Beyond direct patient care, the group supports medical advancement through the Mid-Atlantic Permanente Research Institute (MAPRI), which conducts extensive clinical trials and health services research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mid-Atlantic Permanente Medical Group.